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Letter to the Editor, BJOG Exchange 
Author's reply re: Uterine Transplantation in Transgender Women: Medical, 
Legal and Ethical Considerations 
Dear Editor, 
I thank you for the opportunity to respond to the letter submitted in response to my 
mini-commentary on uterine transplantation in transgender women.1,2 I agree with 
Jones, Alghrani and Smith that current legislation is not well equipped to govern the 
rapidly developing field of uterus transplantation (UTx). UTx straddles transplant and 
reproductive medicine, law, and ethics, with current legislation brought into force 
before UTx was contemplated as a reproductive possibility in the UK. The UK has a 
history of statutorily regulating both transplantation and reproductive medicine, and 
informed debate is needed to consider the shape of any new legislation in this area. 
The authors highlight section 3(2) of the Human Fertilisation and Embryology Act, 
noting that it is not specified here that the woman receiving the embryo must have been 
born female. However, when the legislation was amended, section 3ZA(6) introduced 
the definition that ‘“woman” and “man” include respectively a girl and a boy (from 
birth).’ 
In the limited time available, I have been unable to locate a reason for the introduction 
of section 3ZA(6). This definition first appeared in the 2007 draft Bill and it appears was 
introduced without controversy, with the debate in Parliament centred around the 
issues of hybrid embryos, reproductive cloning, and mitochondrial donation.3 Without 
access to any meaningful and informed debate as to the inclusion of this definition it is 
not possible to conclude definitively on the reasoning behind it. 
I agree with Jones, Alghrani, and Smith that this section may conflict with the Gender 
Recognition Act 2004 and be subject to legal challenges on the basis of human rights 
breaches. However, until a legal challenge is brought and clarification given, any 
medical practitioner who performs an embryo transfer to a transgender woman who 
has undergone UTx is at risk of being subject to the sanctions of the Human Fertilisation 
and Embryology Act (a fine and/or imprisonment up to 10 years). The Act is explicit in 
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its definition, and anything other than a strict interpretation of this provision is hard to 
foresee. 
I am not convinced of the arguments that there is a right to gestate for cisgender 
women, transgender women, or men;4 within the context of the evolving and rapid 
progress being made in UTx the right to gestate requires further examination. There 
may well be persuasive reasons for limiting a right to gestate to cisgender women. 
Indeed, should a human rights challenge be brought the establishment of a right to 
gestate will be influential. The European Court of Human Rights may find that the right 
to gestate falls within the margin of appreciation and that if a legitimate aim can be 
shown for interfering with that right, no breach will be found. This is speculative and as 
such I look forward to the discussion, debate, and development of medicine, law and 
ethics in this area. 
N Hammond-Browning 
Senior Lecturer in Law 
University of Gloucestershire 
Oxstalls Campus 
Oxstalls Lane 
Longlevens 
Gloucester 
GL2 9HW 
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